Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP881015.RAXuBNrMTmfe2k3CbQoyI6571JX--AkHgozC7kNmYLgIc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP881015.RAXuBNrMTmfe2k3CbQoyI6571JX--AkHgozC7kNmYLgIc130_assertion type Assertion NP881015.RAXuBNrMTmfe2k3CbQoyI6571JX--AkHgozC7kNmYLgIc130_head.
- NP881015.RAXuBNrMTmfe2k3CbQoyI6571JX--AkHgozC7kNmYLgIc130_assertion description "[We used the immunohistochemical technique to divide 255 cases of breast cancer, stages II and III, into four subtypes according to estrogen receptor/progesterone receptor and Her-2 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881015.RAXuBNrMTmfe2k3CbQoyI6571JX--AkHgozC7kNmYLgIc130_provenance.
- NP881015.RAXuBNrMTmfe2k3CbQoyI6571JX--AkHgozC7kNmYLgIc130_assertion evidence source_evidence_literature NP881015.RAXuBNrMTmfe2k3CbQoyI6571JX--AkHgozC7kNmYLgIc130_provenance.
- NP881015.RAXuBNrMTmfe2k3CbQoyI6571JX--AkHgozC7kNmYLgIc130_assertion SIO_000772 21422149 NP881015.RAXuBNrMTmfe2k3CbQoyI6571JX--AkHgozC7kNmYLgIc130_provenance.
- NP881015.RAXuBNrMTmfe2k3CbQoyI6571JX--AkHgozC7kNmYLgIc130_assertion wasDerivedFrom befree-2016 NP881015.RAXuBNrMTmfe2k3CbQoyI6571JX--AkHgozC7kNmYLgIc130_provenance.
- NP881015.RAXuBNrMTmfe2k3CbQoyI6571JX--AkHgozC7kNmYLgIc130_assertion wasGeneratedBy ECO_0000203 NP881015.RAXuBNrMTmfe2k3CbQoyI6571JX--AkHgozC7kNmYLgIc130_provenance.